重組蛋白

重組蛋白質(zhì)是分析生物相互作用的有用工具。在研究實(shí)驗(yàn)室中使用了大量的重組蛋白質(zhì),包括商業(yè)蛋白質(zhì)和在特定研究項(xiàng)目中生成的蛋白質(zhì)。它們?cè)谠S多應(yīng)用中發(fā)揮著關(guān)鍵作用。
如果您正在尋找具有優(yōu)良質(zhì)量(驗(yàn)證的生物活性,較低的內(nèi)毒素水平和高純度)的重組蛋白質(zhì)來(lái)支持您的研究,您來(lái)對(duì)地方了。
經(jīng)過(guò)18年的發(fā)展,華美生物已經(jīng)建立了從原核到真核的五大系統(tǒng),用于表達(dá)重組蛋白質(zhì)。我們擁有一系列蛋白質(zhì)表達(dá)和純化技術(shù),包括基于桿狀病毒外膜蛋白(OMP)的蛋白質(zhì)表達(dá)技術(shù),以及膜蛋白表達(dá)技術(shù)等。
產(chǎn)品特點(diǎn)
- 超過(guò)13,000種重組蛋白覆蓋大多數(shù)基因/靶點(diǎn);
- 5種表達(dá)系統(tǒng),包括大腸桿菌(E.coli)、酵母、桿狀病毒感染的昆蟲(chóng)細(xì)胞、哺乳動(dòng)物細(xì)胞和體外大腸桿菌。而體外大腸桿菌表達(dá)系統(tǒng)是華美生物的獨(dú)特表達(dá)系統(tǒng)。與傳統(tǒng)蛋白表達(dá)系統(tǒng)相比,體外大腸桿菌省略了許多過(guò)程,如質(zhì)粒轉(zhuǎn)化、細(xì)胞培養(yǎng)、收集、破碎和離心等,大大提高了工作效率。
- 多種標(biāo)簽,包括His、GST、Flag、MBP等。
- 廣泛應(yīng)用,包括抗原、細(xì)胞分析、結(jié)合分析/蛋白質(zhì)相互作用、細(xì)胞培養(yǎng)-無(wú)血清培養(yǎng)基、藥物相關(guān)研究、體外酶活性、ELISA標(biāo)準(zhǔn)及其原料、體內(nèi)研究、質(zhì)譜標(biāo)準(zhǔn)、蛋白芯片、SDS-PAGE控制、蛋白質(zhì)結(jié)構(gòu)分析(晶體/電子顯微鏡)。
- 多種物種,包括人類、小鼠、大鼠、兔子、豚鼠、雞、猴子、豬等。
- 無(wú)動(dòng)物副產(chǎn)品的動(dòng)物源性重組蛋白質(zhì)。華美生物已開(kāi)發(fā)出無(wú)動(dòng)物副產(chǎn)品接觸的重組蛋白質(zhì)產(chǎn)品線。
重組蛋白目錄
以下是所有重組蛋白的目錄。您可以在目錄中找到適合您研究的蛋白質(zhì),或在本網(wǎng)站頭部的搜索框中搜索它們。
如果您找不到您需要的抗體,請(qǐng)查看華美生物蛋白質(zhì)定制服務(wù)。
通過(guò)選擇目標(biāo)名稱的首字母瀏覽產(chǎn)品。
產(chǎn)品名稱 | 貨號(hào) | 規(guī)格 |
---|---|---|
Recombinant Borrelia recurrentis Ribosomal RNA small subunit methyltransferase H (rsmH) | CSB-YP466560BUK CSB-EP466560BUK CSB-BP466560BUK CSB-MP466560BUK CSB-EP466560BUK-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
Recombinant Borrelia recurrentis Ribonuclease P protein component (rnpA) | CSB-YP466561BUK CSB-EP466561BUK CSB-BP466561BUK CSB-MP466561BUK CSB-EP466561BUK-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
Recombinant Debaryomyces hansenii Protein TIF31 homolog (TIF31), partial | CSB-YP466562DIS CSB-EP466562DIS CSB-BP466562DIS CSB-MP466562DIS CSB-EP466562DIS-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
Recombinant Debaryomyces hansenii Lipoyl synthase, mitochondrial (DEHA2G18854g) | CSB-YP466563DIS CSB-EP466563DIS CSB-BP466563DIS CSB-MP466563DIS CSB-EP466563DIS-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
Recombinant Saccharomyces cerevisiae Mitochondrial distribution and morphology protein 10 (MDM10) | CSB-YP466564SVH CSB-EP466564SVH CSB-BP466564SVH CSB-MP466564SVH CSB-EP466564SVH-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
Recombinant Saccharomyces cerevisiae Probable zinc metalloprotease AWRI1631_21620 (AWRI1631_21620), partial | CSB-YP466565SVH CSB-EP466565SVH CSB-BP466565SVH CSB-MP466565SVH CSB-EP466565SVH-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
Recombinant Saccharomyces cerevisiae Alpha-glucosides permease MPH3 (MPH3), partial | CSB-YP466566SVH CSB-EP466566SVH CSB-BP466566SVH CSB-MP466566SVH CSB-EP466566SVH-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
Recombinant Saccharomyces cerevisiae Mitochondrial translation factor ATP22 (ATP22), partial | CSB-YP466567SVH CSB-EP466567SVH CSB-BP466567SVH CSB-MP466567SVH CSB-EP466567SVH-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
Recombinant Saccharomyces cerevisiae Regulator of rDNA transcription protein 5 (RRT5) | CSB-YP466568SVH CSB-EP466568SVH CSB-BP466568SVH CSB-MP466568SVH CSB-EP466568SVH-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
Recombinant Saccharomyces cerevisiae Oxidant-induced cell-cycle arrest protein 5 (OCA5), partial | CSB-YP466569SVH CSB-EP466569SVH CSB-BP466569SVH CSB-MP466569SVH CSB-EP466569SVH-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
Recombinant Saccharomyces cerevisiae Altered inheritance of mitochondria protein 46, mitochondrial (AIM46) | CSB-YP466570SVH CSB-EP466570SVH CSB-BP466570SVH CSB-MP466570SVH CSB-EP466570SVH-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
Recombinant Saccharomyces cerevisiae Cell wall mannoprotein CIS3 (CIS3) | CSB-YP466571SVH CSB-EP466571SVH CSB-BP466571SVH CSB-MP466571SVH CSB-EP466571SVH-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
Recombinant Saccharomyces cerevisiae RNA annealing protein YRA2 (YRA2) | CSB-YP466572SVH CSB-EP466572SVH CSB-BP466572SVH CSB-MP466572SVH CSB-EP466572SVH-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
Recombinant Saccharomyces cerevisiae Suppressor of lethality of KEX2 GAS1 double null mutant protein 1 (SKG1), partial | CSB-YP466573SVH CSB-EP466573SVH CSB-BP466573SVH CSB-MP466573SVH CSB-EP466573SVH-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
Recombinant Saccharomyces cerevisiae Maintenance of mitochondrial morphology protein 1 (MMM1), partial | CSB-YP466574SVH CSB-EP466574SVH CSB-BP466574SVH CSB-MP466574SVH CSB-EP466574SVH-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
Recombinant Saccharomyces cerevisiae Serine/threonine-protein kinase STE11 (STE11), partial | CSB-YP466575SVH CSB-EP466575SVH CSB-BP466575SVH CSB-MP466575SVH CSB-EP466575SVH-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
Recombinant Saccharomyces cerevisiae ATPase expression protein 2, mitochondrial (AEP2), partial | CSB-YP466576SVH CSB-EP466576SVH CSB-BP466576SVH CSB-MP466576SVH CSB-EP466576SVH-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
Recombinant Saccharomyces cerevisiae Topoisomerase I damage affected protein 7 (TDA7), partial | CSB-YP466577SVH1 CSB-EP466577SVH1 CSB-BP466577SVH1 CSB-MP466577SVH1 CSB-EP466577SVH1-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
Recombinant Saccharomyces cerevisiae Enhancer of translation termination 1 (ETT1) | CSB-YP466578SVH CSB-EP466578SVH CSB-BP466578SVH CSB-MP466578SVH CSB-EP466578SVH-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
Recombinant Saccharomyces cerevisiae Genetic interactor of prohibitins 3, mitochondrial (GEP3), partial | CSB-YP466579SVH CSB-EP466579SVH CSB-BP466579SVH CSB-MP466579SVH CSB-EP466579SVH-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
有用資源
什么是重組蛋白?
重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開(kāi)發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開(kāi)發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。
第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。
第二條:如何選擇合適的表達(dá)載體?
表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。
根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見(jiàn)問(wèn)題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。
引用資料
Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023
Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023
Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023
Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023
Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022